NovoCure (NVCR) Other Non-Current Liabilities (2014 - 2025)
NovoCure (NVCR) posted quarterly Other Non-Current Liabilities of $19000.0 for Q3 2025, up 5.56% year-on-year from $18000.0 in Q3 2024, and up 5.56% on a QoQ basis from $18000.0 in Q2 2025.
NovoCure (NVCR) Other Non-Current Liabilities (2014 - 2025) Analysis & Trends
NovoCure (NVCR) has reported Other Non-Current Liabilities for 12 consecutive years, with $19000.0 the latest figure, recorded in Q3 2025.
- Quarterly Other Non-Current Liabilities rose 5.56% year-over-year to $19000.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $19000.0 (up 5.56% YoY) and the FY2024 annual result came in at $18000.0, changed 0.0% from the prior year.
- Other Non-Current Liabilities rose to $19000.0 in Q3 2025 per NVCR's latest filing, from $18000.0 in the prior quarter.
- Over the last five years, Other Non-Current Liabilities for NVCR reached as high as $379000.0 in Q3 2021 and fell as low as $18000.0 in Q4 2023.
- A 5-year average of $112368.4 and a median of $119000.0 in 2023 frame the typical range for Other Non-Current Liabilities.
- Annual changes were most pronounced in 2021 — Other Non-Current Liabilities soared 125.6% — and 2023, when it tumbled 87.84%.
- Year by year, Other Non-Current Liabilities stood at $166000.0 in 2021, then slipped by 10.84% to $148000.0 in 2022, then slumped by 87.84% to $18000.0 in 2023, then changed by 0.0% to $18000.0 in 2024, then climbed by 5.56% to $19000.0 in 2025.
- According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $19000.0, $18000.0, and $18000.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | NovoCure | 2.28 Bn | 1.85 Bn | 142.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 19,000.00 |
| Jun 30, 2025 | 18,000.00 |
| Mar 31, 2025 | 18,000.00 |
| Dec 31, 2024 | 18,000.00 |
| Sep 30, 2024 | 18,000.00 |
| Jun 30, 2024 | 18,000.00 |
| Mar 31, 2024 | 18,000.00 |
| Dec 31, 2023 | 18,000.00 |
| Sep 30, 2023 | 75,000.00 |
| Jun 30, 2023 | 119,000.00 |
| Mar 31, 2023 | 136,000.00 |
| Dec 31, 2022 | 148,000.00 |
| Sep 30, 2022 | 222,000.00 |
| Jun 30, 2022 | 239,000.00 |
| Mar 31, 2022 | 156,000.00 |
| Dec 31, 2021 | 166,000.00 |
| Sep 30, 2021 | 379,000.00 |
| Jun 30, 2021 | 173,000.00 |
| Mar 31, 2021 | 177,000.00 |
| Dec 31, 2020 | 337,000.00 |